associated with a zyban information risk of seizures,clinicians should not prescribe doses over 300 mg/day for smoking cessation. The risk ofseizures is also related to patient factors, clinical situation, zyban information concurrent medications,which must be considered in selection of patients for therapy with zyban information ZYBAN zyban information discontinued.

Infrequent were accommodation abnormality zyban information dry eye. Also observed were deafness, increased intraocular pressure, and mydriasis.Urogenital: Frequent was urinary frequency. Infrequent were zyban information polyuria, and urinary urgency. Also observed were abnormal ejaculation, cystitis, dyspareunia, dysuria, gynecomastia, menopause, zyban information erection, prostate disorder, salpingitis, urinary incontinence, urinary retention, urinary tract zyban information and vaginitis.Drug zyban information And DependenceZYBAN is likely to have a low abuse potential.Humans: There zyban information zyban information few reported cases of drug dependence and withdrawal symptoms associated with the immediate-release formulation of bupropion. In human studies of abuse zyban information individuals experienced with drugs of zyban information reported that bupropion produced a feeling zyban information euphoria and desirability. In zyban information subjects, a single dose of 400 mg (1.33 times the recommended daily dose) of bupropion produced mild amphetamine-like effects compared to placebo on the.

mild stereotyped behavioral response, and zyban information rates of responding in several.